Did you know?
ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.
Free Newsletter
Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!
Free Report
Seventeen early to mid-stage companies from the Pearl...
Bayer HealthCare China discussed the...
The Keynote Panel from the recently...
The 7th ChinaBio® Investor Forum granted “Most...
Suzhou Natong BioNanotechnology signed a funding...
CMOs will continue their 20% CAGR to $2 billion in 2010,...
WuXi PharmaTech (药明康德), continuing the string of...
Qiming Venture Partners announced a 250 million RMB...
China life science IPOs raised $5.4 billion in the last...
Shanghai Pharmaceuticals will raise 8 billion RMB ($1.2...
ChinaBio® News
Greg Scott Interviewed at BIO-Europe Spring
How to bring your China assets to China in 8 minutes
"Mr. Bio in China."
Mendelspod Interview
Multinational pharma held to a higher standard in China
